News

All News

In Random Mold Tests at 25 Denver Dispensaries, 80 Percent Fail

In late 2019, the City of Denver and the Denver Department of Health and Environment conducted random tests of more than two dozen local dispensaries to learn more about potential yeast and mold issues with marijuana. Of the reports filed between September 9 and September 11, 2019, twenty listed at least one or more hold

Read More »

IASIC Speaker Series Presents Neuroscience of Addiction: Prevention Implications & Application

The International Academy on the Science and Impact of Cannabis (IASIC) is excited to present the IASIC Speaker Series. Presented free of charge, this ongoing educational seminar series will focus on the science, data and peer-reviewed research surrounding marijuana and will be led by international medical experts. This non-partisan and non-political series is continually developed,

Read More »

Cannabis manufacturer Select mixed up THC and CBD products, Oregon says, and that’s why unsuspecting consumers got high

State regulators say the Oregon manufacturer Select, also known as Cura Cannabis, evidently mixed up two lines of products at its Portland manufacturing site. A CBD product, at left, was not supposed to contain THC, but bottles sold contained high levels of the psychoactive ingredient associated with marijuana. A THC product, at right, was sold

Read More »

Marijuana Use Can Cause Schizophrenia

This statement can be made based on the Bradford Hill criteria. Visit the IASIC library to read more about the Bradford Hill criteria and various adverse effects of marijuana. People argue the difference between causation and association. This was the same argument held 100 years ago with tobacco. How can one prove that black lungs and cancer

Read More »

IASIC Speaker Series Presents: Legalized Cannabis in CO Emergency Departments

The International Academy on the Science and Impact of Cannabis (IASIC) is excited to present the IASIC Speaker Series. Presented free of charge, this ongoing educational seminar series will focus on the science, data and peer-reviewed research surrounding marijuana and will be led by international medical experts. This non-partisan and non-political series is continually developed,

Read More »

Dietary Supplement Labeling

CBD has over 500 drug interactions and side effects include liver damage and suicide risk. That is why FDA is stepping up warnings on CBD products. Consumer protection and Science is important. Visit the IASIC library to learn more about CBD and Drug interactions. Read the full article here: https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/cannafyl-611957-03012021

Read More »

Case Reports on the Failure of Smoking Marijuana to Prevent Relapse to Use of Opiates in Adolescents/Young Adults With Opiate Use Disorder

Case Reports on the Failure of Smoking Marijuana to Prevent Relapse to Use of Opiates in Adolescents/Young Adults With Opiate Use Disorder Twenty-six adolescent/young adult patients with opioid use disorder smoked marijuana in an attempt to avoid relapse to opiate use. In each case, smoking marijuana increased cravings and urges for opiates and promoted opiate

Read More »

Listen to podcast High Truths on Drugs and Addiction on your favorite platform. ​Hightruth.com

Most Recent News

Libby Stuyt Interview on Randy Tobler show

Exciting News! Libby Stuyt’s Interview on Randy Tobler Show! Hey everyone, we wanted to share some thrilling news! The brilliant Dr. Libby Stuyt recently had an enlightening interview on Randy Tobler Show. Dr. Stuyt is known for her groundbreaking work in the field of addiction medicine and mental health. Her insights are nothing short of

Read More »

Balancing risks and benefits of cannabis use: umbrella review of meta-analyses of randomised controlled trials and observational studies

Introduction Cannabis contains over 100 cannabinoids, of which Δ9-tetrahydrocannabinol and cannabidiol are the most clinically relevant. Tetrahydrocannabinol is a partial agonist at CB1 and binds CB2 receptors. CB1 is widely expressed by central and peripheral neurones but also by immune cells and other type of cells in the brain and in the periphery, and when

Read More »

IASIC Speaker Series Presents: Case Report on Cannabis-Induced Acute Encephalopathy in Elderly After Taking CBD

The International Academy on the Science and Impact of Cannabis (IASIC) is excited to present the IASIC Speaker Series. Presented free of charge, this ongoing educational seminar series will focus on the science, data and peer-reviewed research surrounding marijuana and will be led by international medical experts. This non-partisan and non-political series is continually developed,

Read More »
Scroll to Top